VIM and lung cancer: By contrast, silencing VAL in cultured primary lung cancer cells (LAD3) originated from a stage III LAD patient’s primary lung tumor, in which VAL was also highly expressed and able to bind Vimentin protein (Fig. 4b), significantly suppressed the protein level rather than the mRNA level of Vimentin (Fig. 5c).